| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3281638 | Clinical Gastroenterology and Hepatology | 2014 | 7 Pages |
Abstract
Filaggrin, ZO-3, and claudin-1 (but not ZO-1 or ZO-2) are detected in the esophageal mucosa of patients with EoE treated with steroids and individuals without esophageal disease. Without treatment, spongiosis increases, corresponding with reduced levels of filaggrin, ZO-3, and claudin-1. Loss of tight junction regulators and dilation of intercellular spaces appear to be involved in the pathophysiology of EoE and could be targets for treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
David A. Katzka, Ravikanth Tadi, Thomas C. Smyrk, Eesha Katarya, Anamay Sharma, Deborah M. Geno, Michael Camilleri, Prasad G. Iyer, Jeffrey A. Alexander, Navtej S. Buttar,